Table 1 Patients demographic and baseline characteristics
Characteristics | Test (n = 112) | Reference (n = 56) | p value |
|---|---|---|---|
Gender | |||
Male | 22 (19.6) | 9 (16.1) | 0.675* |
Female | 90 (80.4) | 47 (83.9) | |
Age (years) | 43.90 ± 11.37 | 40.8 ± 9.99 | 0.088** |
Height (cm) | 158.27 ± 7.03 | 156.90 ± 7.22 | 0.240** |
Weight (Kg) | 58.58 ± 11.52 | 56.76 ± 9.47 | 0.310** |
BMI (Kg/m2) | 23.42 ± 4.88 | 23.08 ± 3.74 | 0.646** |
Race | |||
Asian | 112 (100) | 56 (100) | 0.557* |
RA Score | 8.96 | 9.08 | NA |
ACR Response Criteria | |||
Swollen Joint Count (SJC) | 24.3 ± 13.24 | 23.8 ± 11.62 | 0.794 |
Tender Joint Count (TJC) | 29.1 ± 12.99 | 29.9 ± 11.95 | 0.695 |
Patient’s Assessment of Pain | 80.7 ± 8.77 | 80.6 ± 10.02 | 0.957 |
Patient’s Global Assessment of Disease Activity | 79.3 ± 9.90 | 76.8 ± 11.58 | 0.162 |
Physician’s Global Assessment of Disease Activity | 76.6 ± 8.85 | 76.6 ± 9.54 | 0.995 |
Patient’s assessment of Physical Function | 2.0 ± 0.40 | 1.9 ± 0.45 | 0.077 |
Acute Phase Reactant (CRP (mg/dL)) | 24.8 ± 28.61 | 22.7 ± 22.64 | 0.632 |
DAS28-CRP | 6.6 ± 0.84 | 6.5 ± 0.83 | 0.336 |
HAQ-DI | 2.0 ± 0.40 | 1.9 ± 0.45 | 0.0775 |
IL-6 level | 15.9 ± 15.78 | 18.0 ± 20.87 | 0.705 |